Asia Pacific Biopsy Devices Market Size & Outlook
Asia Pacific biopsy devices market, 2018-2030 (US$M)
Related Markets
Asia Pacific biopsy devices market highlights
- The Asia Pacific biopsy devices market generated a revenue of USD 415.0 million in 2023.
- The market is expected to grow at a CAGR of 10.3% from 2024 to 2030.
- In terms of segment, needle-based biopsy guns was the largest revenue generating product in 2023.
- Biopsy Forceps is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 415.0 million |
| Market revenue in 2030 | USD 826.7 million |
| Growth rate | 10.3% (CAGR from 2023 to 2030) |
| Largest segment | Needle-based biopsy guns |
| Fastest growing segment | Biopsy Forceps |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps |
| Key market players worldwide | Cardinal Health Inc, Hologic Inc, Danaher Corp, Conmed Corp, Cook Medical, Inrad Optics Inc, TransMedics Group Inc, DTR Medical, Gallia County Health Department |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.4% of the global biopsy devices market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 826.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopsy Devices Market Scope
Biopsy Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific biopsy devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopsy devices market will help companies and investors design strategic landscapes.
Needle-based biopsy guns was the largest segment with a revenue share of 43.95% in 2023. Horizon Databook has segmented the Asia Pacific biopsy devices market based on needle-based biopsy guns, biopsy guidance systems, biopsy needles, biopsy forceps covering the revenue growth of each sub-segment from 2018 to 2030.
- Asia Pacific Biopsy Devices Product Outlook (Revenue, USD Million, 2018-2030)
- Needle-based Biopsy Guns
- Vacuum-assisted Biopsy (VAB) Devices
- Fine Needle Aspiration Biopsy (FNAB) Devices
- Core Needle Biopsy (CNB) devices
- Biopsy Guidance Systems
- Manual
- Robotic
- Biopsy Needles
- Disposable
- Reusable
- Biopsy Forceps
- General Biopsy Forceps
- Hot Biopsy Forceps
- Others
- Brushes
- Curettes
- Punches
- Needle-based Biopsy Guns
Reasons to subscribe to Asia Pacific biopsy devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific biopsy devices market databook
-
Our clientele includes a mix of biopsy devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific biopsy devices market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific biopsy devices market size, by country, 2018-2030 (US$M)
Asia Pacific Biopsy Devices Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
